Our goal is to improve short- and long-term outcomes for pediatric acute liver failure (PALF) through a better understanding of patient phenotypes, reassessment of risk classifications, and associating early events to outcome at one year. We will integrate two research efforts (Vodovotz-3U01 DK- 072146-05S1 and Roberts-1R21DK084201-01) currently collaborating with the PALF Study Group (NIH/NIDDK U01 DK072146-05) which are (1) modeling PALF as a complex biological system using physiological and inflammatory biomarkers and (2) developing models to represent the liver transplant (LT) decisions In PALF. To examine our hypotheses that clinical, biochemical, genomic, proteomic, metabolomic, immunologic, and cytokine analyses in PALF can be used to accurately define phenotypes that respond favorably to directed therapy (e.g., immunomodulation) as well as predict disease progression, including potential for spontaneous recovery or risk of death, all of which will provide a platform on which computer/informatics-based (e.g., in silico) studies can inform the design and conduct of clinical trials, and evaluate the impact of therapeutic decisions, including LT;we propose these Aims:
Aim 1 : To comprehensively characterize PALF phenotypes utilizing traditional clinical, biochemical, diagnostic, and management profiles supplemented by immune. Inflammatory and liver regeneration markers to identify factors that explain variations in outcomes for PALF phenotypes. Outcomes Include survival, LT, neurocognitive function, health-related quality of life (HRQOL), depression and post-traumatic stress disorder (PTSD) 6 months and 1 year after enrollment.
Aim 2 : To model the dynamics of PALF within and between distinct phenotypes using serially collected clinical, physiological, and biomarker data. Statistical modeling techniques will be augmented with models used to represent complex biological systems to more accurately reflect the dynamic nature of PALF. The data and models will be utilized to create a computer-based or "in silico" analog of PALF to simulate interventional studies and to assess treatment, including LT decision processes and to estimate the impact of improved decision-making on organ allocation.
We will change the paradigm of research and patient management in PALF and will: 1) Improve mechanistic understanding of PALF;2) test the use of computational modeling in a this rare and complex medical condition 3) test in computer models (in silico) clinical trials of novel therapies, 4) identify cohorts within PALF phenotypes amenable to directed therapy and 5) improve LT decision making and inform organ allocation policy.
|Schwarz, Kathleen B; Dell Olio, Dominic; Lobritto, Steven J et al. (2014) Analysis of viral testing in nonacetaminophen pediatric acute liver failure. J Pediatr Gastroenterol Nutr 59:616-23|
|Schwarz, Kathleen B; Olio, Dominic Dell; Lobritto, Steven J et al. (2014) An Analysis of Viral Testing in non-Acetaminophen (non-APAP) Pediatric Acute Liver Failure (PALF). J Pediatr Gastroenterol Nutr :|
|Aerts, Jean-Marie; Haddad, Wassim M; An, Gary et al. (2014) From data patterns to mechanistic models in acute critical illness. J Crit Care 29:604-10|
|Squires, Robert H; Dhawan, Anil; Alonso, Estella et al. (2013) Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology 57:1542-9|
|Sundaram, Vinay; Shneider, Benjamin L; Dhawan, Anil et al. (2013) King's College Hospital Criteria for non-acetaminophen induced acute liver failure in an international cohort of children. J Pediatr 162:319-23.e1|
|Arciero, Julia C; Mi, Qi; Branca, Maria et al. (2013) Using a continuum model to predict closure time of gaps in intestinal epithelial cell layers. Wound Repair Regen 21:256-65|
|Lu, Brandy R; Zhang, Song; Narkewicz, Michael R et al. (2013) Evaluation of the liver injury unit scoring system to predict survival in a multinational study of pediatric acute liver failure. J Pediatr 162:1010-6.e1-4|
|Bucuvalas, John; Filipovich, Lisa; Yazigi, Nada et al. (2013) Immunophenotype predicts outcome in pediatric acute liver failure. J Pediatr Gastroenterol Nutr 56:311-5|
|Vodovotz, Yoram; Billiar, Timothy R (2013) In silico modeling: methods and applications to trauma and sepsis. Crit Care Med 41:2008-14|
|Namas, Rajaie A; Metukuri, Mallikarjuna R; Dhupar, Rajeev et al. (2011) Hypoxia-induced overexpression of BNIP3 is not dependent on hypoxia-inducible factor 1ýý in mouse hepatocytes. Shock 36:196-202|
Showing the most recent 10 out of 18 publications